Articles

Browse our regulatory articles below or search through our archive.

 


 

HOW MD&M WEST ATTENDEES CAN OVERCOME REGULATORY CHALLENGES

by Arazy Group | Feb 07, 2017
Over the next three days, MedTech professionals will be heading to the 32nd annual MD&M West Conference. While it is important for them to define design techniques and development strategies, as well as leverage the latest breakthroughs in value-based product development, it is just as important to focus on overcoming regulatory challenges.

In order to sell a medical or in vitro diagnostic (IVD) device in a particular country, it must be registered with the local regulatory agency. But without the right expertise and tools, obtaining premarket approval for devices can be a challenge —  regardless of their level of risk, indications of use and technical specifications. And yet, the practice of regulatory affairs remains a fragmented, expensive and inefficient process that is managed manually, mostly through local distributors and consultants.

Regulatory intelligence and registration tool LICENSALE.COM is transforming the way medical and IVD device registration is managed. Being rapidly implemented all over the world, the cloud-based solution can be customized to fit a MedTech firm’s specific needs so it can best meet its business objectives.

With LICENSALE.COM MedTech manufacturers can:

• Reduce regulatory costs by as much as 50% and get approvals for a fixed price
• Expedite time-to-market by 100%
• Quickly gain access to 100+ markets across the globe and even process multiple market clearance applications simultaneously
• Easily control and trace past, present and future registration processes
• Retain ownership of licenses

Through LICENSALE.COM global radiation therapy giant Elekta was able to obtain regulatory approval for 78 products in 16 countries – all in less than a year. If you would like to experience this level of success, contact us today, and we’ll discuss how to transform your regulatory pathway.





 
 
 
 
Category:
  • Blog
Tags:
latest news
  • Apr 9 2018
    MDSAP Transition in Canada

    Health Canada is allowing a "grandfather" period in 2019 for applicants who do not have an MDSAP certificate issued by December 31, 2018....

    Read More
  • Apr 9 2018
    REGULATORY UPDATE - ALPHA BIO

    Italy: Alpha Bios' GSTK (Implant Mount CS) was approved for sale with LICENSALE.COM®....

    Read More
  • Mar 26 2018
    REGULATORY UPDATE - DR. KORMAN LABORATORIES

    Peru: Dr. Korman Laboratories' Dermal Fillers were approved for sale with LICENSALE.COM®....

    Read More
  • Mar 22 2018
    REGULATORY UPDATE - CLARIUS MOBILE HEALTH

    Ecuador: Clarius Mobile Health's Clarius Ultrasound Scanner was approved for sale with LICENSALE.COM®....

    Read More
  • Mar 22 2018
    REGULATORY UPDATE - SPD

    Peru: SPD's CB 9 and CB11 were approved for sale with LICENSALE.COM®....

    Read More

VANCOUVER OFFICE

  • Phone +1 604.681.6888
  • Fax +1 604.681.6822
  • info@arazygroup.com
  •  
  • #350-1333 Johnston Street
  • Pier 32, Granville Island
  • Vancouver, British Columbia
  • Canada V6H 3R9

BACK TO TOP